Enzymatic features of the glucose metabolism in tumor cells

Abstract

Many tumor types exhibit an impaired Pasteur effect, i.e. despite the presence of oxygen, glucose is consumed at an extraordinarily high rate compared with the tissue from which they originate - the so-called 'Warburg effect'. Glucose has to serve as the source for a diverse array of cellular functions, including energy production, synthesis of nucleotides and lipids, membrane synthesis and generation of redox equivalents for antioxidative defense. Tumor cells acquire specific enzyme-regulatory mechanisms to direct the main flux of glucose carbons to those pathways most urgently required under challenging external conditions such as varying substrate availability, presence of anti-cancer drugs or different phases of the cell cycle. In this review we summarize the currently available information on tumor-specific expression, activity and kinetic properties of enzymes involved in the main pathways of glucose metabolism with due regard to the explanation of the regulatory basis and physiological significance of the Warburg effect. We conclude that, besides the expression level of the metabolic enzymes involved in the glucose metabolism of tumor cells, the unique tumor-specific pattern of isozymes and accompanying changes in the metabolic regulation below the translation level enable tumor cells to drain selfishly the blood glucose pool that non-transformed cells use as sparingly as possible. Many tumors exhibit an impaired Pasteur effect, i.e. despite the presence of oxygen, glucose is consumed with an extraordinarily high rate - the so-called 'Warburg effect'. We compile current knowledge on enzymes for glucose utilization in tumor cells and describe how tumor cells acquire specific enzyme-regulatory mechanisms to direct the flux of glucose to those pathways most urgently needed. © 2011 The Authors Journal compilation © 2011 FEBS.